Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Bio-Path Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −19 vs. Q4 2024
- Shares held
- 31.1K
- −287.9K (−90.2%) vs. Q4 2024
- Total value
- $5.29K
- −$364.8K (−98.6%) vs. Q4 2024
- New holders
- 2
- 0 more added
- Sold out
- 21
- 0 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 31,127 | $5.29K | 0.00% | +31,127 | New |
| Jones Financial Companies LLLP | 1 | $0 | 0.00% | +1 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −237,561−100.0% | Sold out |
| Apollon Wealth Management, LLC | 0 | $0 | 0.00% | −14,880−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −13,502−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −12,448−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,237−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,166−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −2,381−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,350−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Synergy Investment Management, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |